Twin Lakes Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $227K | Sell |
4,908
-39
| -0.8% | -$1.81K | 0.14% | 80 |
|
|
2025
Q1 | $302K | Sell |
4,947
-99
| -2% | -$6.04K | 0.2% | 65 |
|
|
2024
Q4 | $285K | Sell |
5,046
-762
| -13% | -$43.1K | 0.18% | 72 |
|
|
2024
Q3 | $301K | Buy |
5,808
+70
| +1% | +$3.62K | 0.19% | 68 |
|
|
2024
Q2 | $238K | Sell |
5,738
-1,325
| -19% | -$55K | 0.16% | 73 |
|
|
2024
Q1 | $383K | Buy |
7,063
+83
| +1% | +$4.5K | 0.26% | 60 |
|
|
2023
Q4 | $358K | Buy |
6,980
+75
| +1% | +$3.85K | 0.25% | 62 |
|
|
2023
Q3 | $401K | Buy |
6,905
+61
| +0.9% | +$3.54K | 0.3% | 58 |
|
|
2023
Q2 | $438K | Buy |
6,844
+55
| +0.8% | +$3.52K | 0.31% | 54 |
|
|
2023
Q1 | $471K | Buy |
6,789
+52
| +0.8% | +$3.6K | 0.35% | 51 |
|
|
2022
Q4 | $485K | Buy |
6,737
+46
| +0.7% | +$3.31K | 0.37% | 50 |
|
|
2022
Q3 | $476K | Buy |
6,691
+47
| +0.7% | +$3.34K | 0.38% | 55 |
|
|
2022
Q2 | $512K | Sell |
6,644
-370
| -5% | -$28.5K | 0.37% | 49 |
|
|
2022
Q1 | $512K | Buy |
7,014
+131
| +2% | +$9.56K | 0.29% | 62 |
|
|
2021
Q4 | $429K | Buy |
6,883
+56
| +0.8% | +$3.49K | 0.23% | 66 |
|
|
2021
Q3 | $404K | Sell |
6,827
-19
| -0.3% | -$1.12K | 0.24% | 64 |
|
|
2021
Q2 | $457K | Sell |
6,846
-250
| -4% | -$16.7K | 0.25% | 58 |
|
|
2021
Q1 | $448K | Buy |
7,096
+205
| +3% | +$12.9K | 0.28% | 58 |
|
|
2020
Q4 | $427K | Buy |
+6,891
| New | +$427K | 0.31% | 57 |
|